SCHEMBL1103524

SCHEMBL1103524

Cc1ccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3c2cnc2ccccc23)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
MET P08581 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
IKBKB O14920 1/20 0.36
KDM4E B2RXH2 2/20 0.36
GPR3 P46089 1/20 0.36
PDPK1 O15530 1/20 0.36
CYP1A2 P05177 1/20 0.35
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35
TOP2A P11388 1/20 0.34
RAB9A P51151 3/20 0.34
MAPT P10636 2/20 0.34
RECQL P46063 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103265 0.92 NPC1 (0.50) NPC1KDM4EGPR3PDPK1TOP2A
SCHEMBL1103530 0.91 MET (0.38) NPC1METPIK3CDPIK3CAMTOR
SCHEMBL1103452 0.91 KDM4E (0.43) NPC1METPIK3CDPIK3CAMTOR
SCHEMBL1103719 0.91 KDM4E (0.43) NPC1METPIK3CDPIK3CAMTOR
SCHEMBL1103522 0.90 KDM4E (0.42) NPC1METPIK3CDPIK3CAMTOR
SCHEMBL1103446 0.90 ESR1 (0.43) NPC1METPIK3CDPIK3CAMTOR
SCHEMBL1103375 0.90 KDM4E (0.42) NPC1METPIK3CDPIK3CAMTOR
SCHEMBL1103531 0.89 ALDH1A1 (0.42) NPC1METPIK3CDPIK3CAMTOR
SCHEMBL1103403 0.88 NPC1 (0.47) NPC1KDM4EPDPK1CYP1A2ESR1
SCHEMBL1103465 0.88 ESR1 (0.42) NPC1METPIK3CDPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 NPC1 1582/4885MET 4191/4885PIK3CD 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.